Article ID Journal Published Year Pages File Type
9194524 Journal of Neuroimmunology 2005 4 Pages PDF
Abstract
Interleukin 4 is a Th2 cytokine with potent anti-inflammatory properties. Protection from autoimmune encephalomyelitis and multiple sclerosis has been achieved with IL-4 therapy and IL-4 deficient mice developed a more severe form of clinical disease. Four polymorphisms within the IL-4 gene are in strong linkage disequilibrium, including one in the promoter at − 590, which controls transcriptional activity. An MS protective role for the heterozygous genotype was confirmed in Spain (exon-1 + 33 C/T: p = 0.003, OR [CI] = 0.57 [0.38-0.84]), probably indicative of an MS protection haplotype at 5q31 locus. No difference among MS clinical forms or age at onset was detected.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , ,